Is it time for a change the case for early application of unrelated allo-SCT for severe aplastic anemia

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Severe aplastic anemia (SAA) is a BM failure syndrome in which allo-SCT remains a highly effective curative option. Its application remains limited by donor availability and by the potential for treatment-related morbidity and mortality. The improved outcomes with unrelated transplantation are a result of the advent of molecular donor-recipient matching, generation of effective novel conditioning regimens, improvement of supportive care and expansion of the donor registry. Decision making regarding the earlier use of unrelated transplant procedures is rapidly evolving. This paper reviews critical data relevant to these treatment options and recommends early consideration of related SCT for patients with SAA who show failure of immune suppressive therapy.

Original languageEnglish (US)
Pages (from-to)1479-1488
Number of pages10
JournalBone Marrow Transplantation
Volume45
Issue number10
DOIs
StatePublished - Oct 2010

Fingerprint

Aplastic Anemia
Tissue Donors
Registries
Decision Making
Therapeutics
Transplantation
Morbidity
Transplants
Mortality

Keywords

  • early application
  • high-resolution typing
  • severe aplastic anemia

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

@article{39229d5a82224eca96cc5aa2f774b56f,
title = "Is it time for a change the case for early application of unrelated allo-SCT for severe aplastic anemia",
abstract = "Severe aplastic anemia (SAA) is a BM failure syndrome in which allo-SCT remains a highly effective curative option. Its application remains limited by donor availability and by the potential for treatment-related morbidity and mortality. The improved outcomes with unrelated transplantation are a result of the advent of molecular donor-recipient matching, generation of effective novel conditioning regimens, improvement of supportive care and expansion of the donor registry. Decision making regarding the earlier use of unrelated transplant procedures is rapidly evolving. This paper reviews critical data relevant to these treatment options and recommends early consideration of related SCT for patients with SAA who show failure of immune suppressive therapy.",
keywords = "early application, high-resolution typing, severe aplastic anemia",
author = "Gabrielle Meyers and Richard Maziarz",
year = "2010",
month = "10",
doi = "10.1038/bmt.2010.134",
language = "English (US)",
volume = "45",
pages = "1479--1488",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Is it time for a change the case for early application of unrelated allo-SCT for severe aplastic anemia

AU - Meyers, Gabrielle

AU - Maziarz, Richard

PY - 2010/10

Y1 - 2010/10

N2 - Severe aplastic anemia (SAA) is a BM failure syndrome in which allo-SCT remains a highly effective curative option. Its application remains limited by donor availability and by the potential for treatment-related morbidity and mortality. The improved outcomes with unrelated transplantation are a result of the advent of molecular donor-recipient matching, generation of effective novel conditioning regimens, improvement of supportive care and expansion of the donor registry. Decision making regarding the earlier use of unrelated transplant procedures is rapidly evolving. This paper reviews critical data relevant to these treatment options and recommends early consideration of related SCT for patients with SAA who show failure of immune suppressive therapy.

AB - Severe aplastic anemia (SAA) is a BM failure syndrome in which allo-SCT remains a highly effective curative option. Its application remains limited by donor availability and by the potential for treatment-related morbidity and mortality. The improved outcomes with unrelated transplantation are a result of the advent of molecular donor-recipient matching, generation of effective novel conditioning regimens, improvement of supportive care and expansion of the donor registry. Decision making regarding the earlier use of unrelated transplant procedures is rapidly evolving. This paper reviews critical data relevant to these treatment options and recommends early consideration of related SCT for patients with SAA who show failure of immune suppressive therapy.

KW - early application

KW - high-resolution typing

KW - severe aplastic anemia

UR - http://www.scopus.com/inward/record.url?scp=77957951343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957951343&partnerID=8YFLogxK

U2 - 10.1038/bmt.2010.134

DO - 10.1038/bmt.2010.134

M3 - Article

VL - 45

SP - 1479

EP - 1488

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 10

ER -